Table 2.
GDF-15 concentrations (ng/L) in 1,159 apparently healthy FHS participants without major cardiovascular, renal, or pulmonary disease
Age | Percentile | ||||||
---|---|---|---|---|---|---|---|
Group (years) |
n | 2.5th | 10th | 50th | 90th | 97.5th | |
Men | 30–39 | 19 | 473 | 483 | 651 | 1,197 | 1,498 |
40–49 | 121 | 535 | 571 | 726 | 1,081 | 1,250 | |
50–59 | 197 | 574 | 655 | 863 | 1,414 | 1,838 | |
60–69 | 104 | 723 | 805 | 1,115 | 1,711 | 2,197 | |
70–79 | 27 | 893 | 1,084 | 1,389 | 2,030 | 5,006 | |
Women | 30–39 | 14 | 520 | 543 | 745 | 1,007 | 1,085 |
40–49 | 180 | 488 | 561 | 762 | 1,172 | 1,574 | |
50–59 | 275 | 557 | 668 | 890 | 1,269 | 1,786 | |
60–69 | 167 | 652 | 784 | 1,025 | 1,553 | 1,833 | |
70–79 | 55 | 845 | 939 | 1,277 | 1,717 | 2,562 |